NCOA2 and endometrial cancer: Interestingly, our unpublished data show that knockdown of SRC-2 alone in Ishikawa human endometrial cancer cells significantly attenuates the ability of this cancer cell line to proliferate, supporting a role for SRC-2 in endometrial cancer cell progression.